arcadeworld| Watson Biotech: In early February, the company obtained preliminary results of a head-to-head clinical trial of the company's nine-valent HPV vaccine and similar vaccines, showing that the vaccine has good safety and immunogenicity

Nature 2024-04-13

同花顺(300033)金融研究中心04月12日讯,有投资者向沃森生物(300142)(300142)提问, 公司股价持续下跌,公司调研中称,9价HPV已经处于撰写临床报告arcadeworld的阶段,既然是撰写临床报告阶段,那么头对头的核心数据中和抗体头对头数据想必是出来了,能否公布下简单的核心数据?

公司回答表示,尊敬的投资者,您好!公司2月初获得一项公司九价HPV疫苗与同类疫苗头对头临床试验的初步结果显示,该疫苗具有良好的安全性和免疫原性。其中4个型别的抗体阳转率为100%,4个型别的抗体阳转率为99%,1个型别的抗体阳转率为91%,公司目前正在基于9价HPV产品临床开发计划,保持与CDE密切沟通交流,积极争取以最优策略推动保护效力临床研究开展。谢谢!

arcadeworld| Watson Biotech: In early February, the company obtained preliminary results of a head-to-head clinical trial of the company's nine-valent HPV vaccine and similar vaccines, showing that the vaccine has good safety and immunogenicity

Comments
Copyright Your WebSite.Some Rights Reserved.
Powered By Z-BlogPHP.